Celerion https://validator.w3.org/feed/docs/rss2.html A Fully Automated Workflow for Gyrolab Assays Home Blog Cardiovascular Safety & Efficacy Trials Single Ascending Dose/Multiple Ascending Dose Thorough QT (TQT) Studies Metabolic Disorder Studies Services Drug-Drug Interaction (DDI) Modeling and Simulation Services About Participant Recruitment Regulatory Product Labeling Studies Bioavailability/Bioequivalence Respiratory Disease Research Metabolite Profiling Services Global Clinical Development Virtual Tour: Inside Celerion’s Bioanalytical Laboratory at Our Lincoln, Nebraska CRO Facilit Rifampin Alternatives for DDI Studies in Response to Nitrosamine Impurities Phoenix, Arizona Lincoln, Nebraska Our Global Locations Early Phase Clinical Services Bioavailability/Bioequivalence-TEST Why Partner with Celerion for ADC Bioanalysis? Solutions Sites Pharmacokinetics/Pharmacodynamics (PK/PD) Analysis Regulatory Medical Writing & Reporting PK/PD Modeling and Analysis Immunogenicity Testing Services Biomarker Analysis Services Leadership Team Biosimilar Testing Services Gene Therapy Analytical Services Belfast, UK Radiolabeled (ADME) Studies Therapeutic Expertise Areas ClinQuick®: Rapid Clinical Trial Execution Monitoring & Project Management Services Clinical Data Science Services Renal & Hepatic Impairment Studies Tobacco Harm Reduction Studies Electronic Data Capture (EDC) Systems Biosimilar Clinical Research Food Effect Studies A Hepatic Impairment Study for a Drug with a Long Half Life Navigating Enrollment & Central Lab Challenges in a Large Pharmacokinetic Study with Severe Renal Impairment A Renal Impairment Study Evaluating Plasma and Intracellular PBMC PK Contact